Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice.
The landscape of non-small cell lung cancer (NSCLC) treatment has rapidly evolved over the past decade. This is exemplified by the use of molecular targeted agents, immunotherapies, and newer technologies such as stereotactic body radiotherapy (SBRT). As the translation of preclinical discoveries into clinical practice continues, the effective dissemination and implementation of evidence-based treatment of NSCLC will remain a foremost challenge for oncologists. To further extend evidence-based medicine into the community setting, community oncologists are being engaged on multiple fronts including leadership and participation in national clinical trials and utilization of internet-based resources.
Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI, 53792, USA.
Stephen A
SA
Rosenberg
Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI, 53792, USA.
Andrew M
AM
Baschnagel
Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3400 Civic Center Blvd, Perelman Center South Pavilion Extension, 10th Floor, Room 134, Philadelphia, PA, 19104, USA.
Stephen J
SJ
Bagley
Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School, 195 Little Albany St, New Brunswick, NJ, 08903, USA. housrina@scarletmail.rutgers.edu.
Nadine
N
Housri
D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000532:radiotherapy*; D019468:Disease Management; D019317:Evidence-Based Medicine; D006801:Humans; D016634:Radiosurgery; D057170:Translational Research, Biomedical
CCOP; Community oncology; Community practice; Evidence-based medicine; Internet; Lung cancer; NCORP; Point of care; Social media; Social networks